Woopen, C.; Dunsche, M.; Al Rahbani, G.K.; Dillenseger, A.; Atta, Y.; Haase, R.; Raposo, C.; Pedotti, R.; Ziemssen, T.; Akgün, K.
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy. Vaccines 2023, 11, 1464.
https://doi.org/10.3390/vaccines11091464
AMA Style
Woopen C, Dunsche M, Al Rahbani GK, Dillenseger A, Atta Y, Haase R, Raposo C, Pedotti R, Ziemssen T, Akgün K.
Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy. Vaccines. 2023; 11(9):1464.
https://doi.org/10.3390/vaccines11091464
Chicago/Turabian Style
Woopen, Christina, Marie Dunsche, Georges Katoul Al Rahbani, Anja Dillenseger, Yassin Atta, Rocco Haase, Catarina Raposo, Rosetta Pedotti, Tjalf Ziemssen, and Katja Akgün.
2023. "Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy" Vaccines 11, no. 9: 1464.
https://doi.org/10.3390/vaccines11091464
APA Style
Woopen, C., Dunsche, M., Al Rahbani, G. K., Dillenseger, A., Atta, Y., Haase, R., Raposo, C., Pedotti, R., Ziemssen, T., & Akgün, K.
(2023). Long-Term Immune Response Profiles to SARS-CoV-2 Vaccination and Infection in People with Multiple Sclerosis on Anti-CD20 Therapy. Vaccines, 11(9), 1464.
https://doi.org/10.3390/vaccines11091464
